Today science sits in silos. Tomorrow it lives in markets.

From our screener: $AUBRAI -- the world's first BioAgent generating and owning onchain IP.

Trained on the mind of @aubreydegrey, powered by @Bioprotocol + Molecule's Proof of Invention rails.

Build for onchain science acceleration👇

Science is still running on feudal infrastructure.
New systems are inevitable.

Bio/acc

Last week, an AI model imagined a cancer treatment -- and got it right.

This week, DrugReflector finds useful compounds 17x faster than traditional research.

The lab is turning into a thinking system --
recursive, transparent, self-improving. 👇

We’re optimizing for safety, not discovery -- producing endless variations of the same drug.

@fedichev explains how Pharma's risk aversion is dangerous for innovation.

An AI model just made -- and experimentally proved -- a new cancer discovery.

Google & Yale’s Cell2Sentence-Scale (27B) generated a hypothesis that turned out to be correct in living cells.

Scientific singularity is already happening. 👇

If developers spent 80% of their time applying to buy a keyboard, tech would be stuck in 1995.

That’s science today -- researchers spend 80% of their time chasing grants, not breakthroughs.
DeSci aims to fix this.

$VITASTEM is live on Molecule!

Aging starts in your blood.

$VITASTEM is the first @Aubrai_-generated IP Token targeting your body’s blood-forming stem cells -- the source of age-related decline. 👇

$DICK is live on Molecule!

@D1ckGPT is a BioAgent transforming men's health from taboo ➝ testable

Designed to give recommendations for men's health optimization while collecting verifiable data to fuel research breakthroughs. 👇

for centuries, research agendas were set by a handful of governments and wealthy donors.

@paulkhls & @CryptoHayes discuss how DeSci rewrites that script.

> blockchain turns community capital into research power.
> funding flows where people believe discovery matters most.

⏳ science runs on long cycles.
⚡ crypto runs on short attention spans.

at DeSci Summit Singapore, @CryptoHayes & our CEO @paulkhls unpacked how to bridge that gap:

> radical transparency: sharing progress, setbacks, and roadmaps with your community.

IP Tokens offer an open, permissionless, decentralized way to fund scientific research onchain -- and then what?

We're designing the DeSci value flywheel; complete economic cycles where scientific breakthroughs fuel the next generation of discoveries

🧵 ⤵️